Metformin Gemax Pharma

Metformin Hydrochloride, the active ingredient in Metformin Gemax Pharma, is a biguanide presented as a tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. GNH USA supplies Metformin Gemax Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Gemax Pharma is indicated for the management of hyperglycaemia in type 2 diabetes mellitus, acting on the metabolic pathway that regulates blood glucose.

Type 2 diabetes mellitus: lowers fasting and post‑prandial glucose levels and helps achieve target HbA1c values.

Metformin Gemax Pharma may cause a range of adverse reactions. Patients should be aware of both common and less frequent but serious events.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhoea. - Metallic taste in the mouth. - Decreased appetite. - Mild headache. - Weight loss: modest reduction in body weight.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe hypoglycaemia: usually when combined with other glucose‑lowering agents. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, pruritus, or angio‑edema. - Vitamin B12 deficiency with long‑term use.

Metformin should be used with caution in specific clinical situations and according to professional guidelines. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic disease: avoid in patients with significant liver impairment. - Cardiovascular status: monitor in patients with unstable heart failure. - Alcohol intake: limit consumption to reduce risk of lactic acidosis. - Pregnancy and lactation: evaluate risk‑benefit ratio with the prescriber. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Metformin may interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations. - Certain antiretrovirals (e.g., didanosine): increase risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of metformin. - Beta‑blockers: can mask hypoglycaemia symptoms. - ACE inhibitors or ARBs: monitor renal function when combined.